IRCT20200105046010N76尚未招募Unknown
Bioequivalence study of Miglustat 100 mg capsule (Miglutan)manufactured by Zistdaru Danesh versus originator brand (Zavesca) in healthy volunteers in the fasted condition
Zistdaru danesh Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcohol and drug addiction
- •History of allergy to Miglustat
研究者
相似试验
招募中
Unknown
Bioequivalence of Miglustat capsuleIRCT20210201050197N7Shahid Beheshti University of Medical Sciences24
招募中
不适用
Comparative bioequivalence study of the miglustat 100-mg Capsules manufactured by Modava Pharmaceutical Company-.IRCT20130313012810N8Modava Pharmaceutical Company24
已完成
不适用
Bioequivalence of miglitol 100mg in Korean subjectsKCT0000770Kolmar Korea40
尚未招募
Unknown
Bioequivalence evaluation of Montelukast 4 mg granule of Actover Pharmaceutical companyIRCT20200625047913N17Hezareh Sevom Futuristic Pharmacist24
尚未招募
1 期
Bioequivalence study of sitagliptin 100 mg film-coated tablet in Thai healthy volunteersThai healthy male and female subjects , Aged 18 to 50 years , BMI were within 18-25 kg/m2 , Good health confirming by physical and clinical.HealthyTCTR20210824012Faculty of Medicine, Chulalongkorn University26